News
SurvivorNet on MSN18h
FDA Loosens Safety Requirements For CAR T-Cell Therapies, Paving The Way For Many More Blood Cancer Patients To Access Innovative TreatmentThe FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback